1. Abrams B.F., Laros R.K.Jr.: Prepregnancy weight, weight gain, and birth weight. Am. J. Obstet. Gynecol., 1986, 154, 503-509.
2. Agarwal K.N., Agarwal D.K., Mishra K.P: Impact of anaemia prophylaxis in pregnancy on maternal hemoglobin, serum ferritin and birth weight. Indian J. Med. Res., 1991, 94, 277-80.
3. Al M.D.M., van Houwelingen A.C., Kester A.D.M. et al.: Maternal essential fatty acid patterns during normal pregnancy and its relationship with the neonatal essential fatty acid status. Br. J. Nutr., 1995, 74, 55-68.
4. Allen L.H.: Pregnancy and iron deficiency: unresolved issues. Nutr. Rev., 1997, 55, 91-101.
5. Arnold R.W.: Retinopathy of prematurity in Alaska. In: Proceedings of the 19th Annual Providence Hospital Perinatal Symposium, Anchorage, AL, 1992.
6. Bailey L.B.: Folate requirements and dietary recommendations. In: Folate in health and disease. Ed: L.B. Bailey. New York Marcel Dekker, 1995.
7. Barker D.J.P.: Mothers, babies and disease in later life. London, Br. Med. J. Publishing Group,1994.
8. Bazan N.G.: The metabolism of omega-3 polyunsaturated fatty acids in the eye: The possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog. Clin. Biol. Res., 1989, 312, 95.
9. Belizan J.M., Villar J., Gonzales L. et al.: Calcium supplementation to prevent hypertensive disorders of pregnancy. N. Engl. J. Med., 1991, 325, 1399-1405.
11. Birch D.G., Birch E.E., Hoffman D.R. et al.: Retinal development in verylow-birth-weight infants fed diets differing in omega-3 fatty acids. Invest. Ophthalmol. Vis. Sei 1992, 33, 2365.
12. Bower C., Stanley F.J.: Dietary folate as a risk factor for neural tube defects: evidence from a case control study in estern Australia. Med. J. Aust. 1989, 150, 613.
13. Brown J.E., Murtaugh M.A., Jacobs D.R.,Jr et al.: Variation in newborn size according to pregnancy weight change by trimester. Am. J. Clin. Nutr., 2002, 76, 205-9.
14. Brzeziński Z.J., Mazurczak T.: Propozycje wprowadzenia profilaktyki pierwotnej wad rozwojowych cewy nerwowej w Polsce. Ped. Pol., 1994, 69, 684.
15. Bucher H.C., Guyatt G.H., Cook R.J. et al.: Effect of calcium supplementation on pregnancy-induced hypertention and preeclampsia: a meta-analysis of randomized controlled trials. J. Am. Med. Assoc., 1996, 275, 1113- 7.
16. Bunin G.R., Kuijten R.R., Buckley J.D. et al.: Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N. Engl. J. Med., 1993, 329, 536.
17. Chien P.F.W, Khan K.S., Arnott N.: Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: an overview of the evidence from randomized trials. Br. J. Obstet. Gynecol., 1996, 103, 1085-91.
18. Colomer J: Anaemia during pregnancy as a risk factor for infant iron deficiency: report from the Valencia Infant Anaemia Cohort (VIAC) study. Paediatr. Perinat. Epidemiol., 1990, 4, 196-204.
19. Conradt A., Weidinger H., Algayer H.: Magnesium therapy decreased the rate if intrauterine fetal retardation, premature rupture of membranes and premature delivery in risk pregnancies treated with betamimetics. Magnesium, 1985, 4, 20-28.
20. Cuskelly G.J., McNulty H., Scott J.M.: Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet, 1996, 347, 657-9.
21. Czeizel A.E., Dudas I.: Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N. Engl. J.Med. 1992, 327, 1832- 5.
22. Delange F.: Administration of iodized oil during pregnancy: a summary of published evidence. Bull. WHO 1996, 74, 101-108.
23. De Maeyer E., Adiels-Tegman M.: The prevalence of anaemia in the world. World Health Stat. Q 1985, 38, 302-16.
24. DHHS PHS Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tbe defects. MMWR, 1992, 41, 1- 7.
25. Doyle W., Crawford M.A. Wynn A.H. et al.: Maternal Magnesium intake and pregnancy outcome. Magnes. Res., 1989, 2, 205-10.
26. Duvekot E.J., de Groot C.J., Bioemenkamp K.W., et al.: Pregnant women with a low milk intake have an increased risk of developing preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol., 2002, 105, 11-4.
27. Expert Advisory Group. Folic acid the prevention of neural tube defects. London, Department of Health, 1992.
29. Godfrey K.M., Barker D.J.P: Fetal nutrition and adult disease. Am. J. Clin. Nutr., 2000, 71(Suppl),1344S-52S.
30. Gregory J.F.: The bioavailability of folate. In: Folate in health and disease. Bailey L.B., ed. New York: Marcel Dekker, 1995.
31. Haggarty P., Abramovich D.R., Page K.: The effect of maternal smoking and ethanol on fatty acid transport by the human placenta. Br. J. Nutr., 2002, 87, 247- 52.
32. Hambidge K.M., Neidner K.H., Walravens P.A.: Zinc, acrodermatitis enteropathica, and congenital malformations. Lancet, 1975, i, 577.
33. Heiland I.B., Smith L., Saarem K.,et al.: Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics, 2003, 111, e39-44.
34. Hemminki E., Starfield B.: Routine administration of iron and vitamins during pregnancy: review of controlled clinical trials. Br. J. Obstet. Gynaecol., 1978, 85, 404-10.
35. Herbert V:. Folate and neural tube defects. Nutr. Today, 1992, November, 30.
36. Hercberg S., Preziosi P., Galan P.: Iron deficiency in Europe. Publ. Health. Nutr., 2001, 4, 537-45.
37. Honein M.A., Paulozzi L.J., Mathews T.J., et al.: Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. J. Am. Med. Assoc., 2001, 285, 2981- 6.
38. Hornstra G.: Essential fatty acids in mothers and their neonates. Am. J. Clin. Nutr., 2000, 71 (Suppl), 1262S-9S.
39. Institute of Medicine, National Academy of Science: Iron Deficiency Anemia: Recommended Guidelines for Prevention, Detection, and Management among US Children and Women in Childbearing Age. Washington, DC. National Academy Press,-1993.
40. Jackson A.A., Robinson S.M.: Dietary guidelines for pregnancy: a review of current evidence. Publ. Health Nutr., 2001, 4 (2B), 625-630.
41. King J.C.: Determinants of maternal zinc status during pregnancy. Am. J. Clin. Nutr., 2000, 71(Suppl), 1334S-43S.
42. Kleinman J.C.: Maternal Weight Gain During Pregnancy: Determinants and Consequences. NCHS Working Paper Series No.33. National Center for Health Statistics, Public Health Service, U.S. Department of Health and Human Services, Hyattsville, 1990.
43. Koebnick C., Heins U.A., Hoffmann I. et al.: Folate status during pregnancy in women is improved by long-term high vegetable intake compared with the average western diet. J. Nutr., 2001, 131, 733-39.
44. Kovacs L., Molnar B.G., Huhn E., et al.: Magnesium substitution in pregnancy. A prospective randomized double-blind study. Geburtshilfe Frauenheilkunde 1988, 48, 595-600.
45. Laurence K.M., James N., Miller M.H., et al.: Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. Br. Med. J., 1981, 282, 1509.
46. Lin-Fu J.S., Anthony M.A.: Folic acid and neural tube defects: A fact sheet for health care providers. Maternal and Child Health Bureau, Health Resources and Services Administration, Public Health Service, 1990.
47. Lucas A., Morley R., Cole T.J.: Breast milk and subsequent intelligence quotient in children born preterm. Lancet, 1992, 339, 261.
48. McDade T.W., Beck M.A., Kuzawa C.W., et al.: Prenatal undernurtirition and postnatal growth are associated with adolescent thymic function. J. Nutr., 2001, 131, 1225-1231.
49. Merialdi M., Carroli G., Villar J., et al.: Nutritional interventions during pregnancy for the prevention or treatment of impaired fetal growth: an overview of randomized controlled trials. J. Nutr., 2003, 133, 1626-31S.
50. Mikhail M.S., Anyaegbunam A., Garfinkel D. et al.: Preeclampsia and antioxidant nutrient: decreased plasma levels of reduced ascorbic acid, alfa-tocoferol, and beta-carotene in women with preeclampsia. Am. J. Obstet. Gynec., 1994, 171, 150.
51. Monsen E.R.: Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium and carotenoids. J. Am. Diet. Assoc., 2000, 100, 637- 640.
52. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet, 1991, 338, 131-7.
53. Naeye R.L.: Weight gain and the outcome of pregnancy. Am. J. Obstet. Gynecol., 1979, 135, 3-9
54. Narodowy Program Zdrowia 1996-2005. Ministerstwo Zdrowia i Opieki Społecznej. Międzyrestortowy Zespól Koordynacyjny Narodowego Programu Zdrowia. Warszawa, 1996.
55. National Health and Medical Research Council. Revised statement on the relationship between dietary folic acid and neural tube defects such as spina bifida. 115th session. Australia: NHMRC,1993.
56. Neuringer M., Anderson G.J., Connor W.E.: The essentiality of n-3 fatty acids for the development and function of the retina and brain. Annu. Rev. Nutr., 1988, 8, 517.
57. Neuringer M., Connor W.E.: N-3 fatty acids in the brain and retina: evidence for their essentiality. Nutr. Rev., 1986, 44, 285.
58. Neuringer M., Connor W.E., Lin D.S., et al.: Biochemical and functional effects of prenatal and postnatal omega-3 fatty acid deficiency on retina and brain in rhezus monkeys. Proc. Natl. Acad. Sei. USA 1986, 83, 4021.
59. Neuringer M., Connor W.E., Van Petten C. et al.: Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys. J. Clin. Invest., 1984, 73, 272.
60. Nutrition During Pregnancy. Institute of Medicine, National Academy of Sciences. National Academy Press. Washington, D.C., 1990.
61. Olsen S.F., Hansen H.S., Sorensen T.I., et al.: Intake of marine fat, rich in (n- 3)-polyunsaturated fatty acids, may increase birthweight by prolonging gestation. Lancet, 1986, 2, 367-9.
62. Olsen S.F, Joensen H.D.: High liveborn birth weights in the Faroes: a comparison betweenbirth weights in the Faroes and in Denmark. J. Epid. Comm. Health, 1985, 39, 27-32.
63. Olsen S.F., Secher N.J.: Low consumption of seafood i early pregnancy as a risk factor for preterm delivery: prospective cohort study. Br. Med. J., 2002, 324, 447.
64. Olsen S.F., Secher N.J., Tabor A., et al.: Randomised clinical trials of fish oil supplementation in high risk pregnancies. Br. J. Obstet. Gynecol., 2000, 107, 382-95.
65. Olsen S.F., Sorensen J.D., Secher N.J., et al.: Randomised controlled trial of effect offish-oil supplementation on pregnancy duration. Lancet, 1992, 339, 1003-7.
66. Osendarp S.J.M., van Raaij J.M.A., Arifeen S.E. et al.: A randomized, placebo-controlled trial of the effect of zinc supplementation during pregnancy on pregnancy outcomes in Bangladeshi urban poor. Am. J. Clin. Nutr., 2000, 71, 114-9.
67. Recommended Dietary Allowances. 10th edition. Washington D.C. National Academy Press, 1989.
68. Rothman K.J., Moore L.L., Singer M.R. et al.: Teratogenicity of high vitamin A intake. N. Engl. J. Med., 1995, 333, 1369-73.
69. Scholl T.O., Hediger M.L., Fischer R.L. et al.: Anemia vs iron deficiency: Increased risk of preterm delivery in a prospective study. Am. J. Clin. Nutr., 1992, 55, 985.
70. Scholl T.O., Hediger M.L., Scholl J.J. et al.: Low zinc intake during pregnancy: its association with preterm and very preterm delivery. Am. J. Epid., 1993, 137, 1115-24.
71. Sebire N.J., Jolly M., Harris J.P .: Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int. J. Obes. Relat. Metab. Disord., 2001, 25, 1175-82.
72. Shoob H.D., Sargent R.G., Thompson S.J., et al.: Dietary methonine is involved in the etiology of neural tube defect-affected pregnancies in humans. J. Nutr., 2001, 131, 2653-8.
73. Sibai B.M., Villar L., Bray E.: Magnesium supplementation during pregnancy. A double-blind randomized controlled clinical trial. Am. J. Obstet. Gynecol., 1989, 161, 115-9-.
74. Sikorski S., Juszkiewicz T., Paszkowski T.: Zinc status in women with premature rupture of membranes at term. Obstet. Gynecol., 1990, 76, 675-7.
75. Smithells R.W., Nevin N.C, Seller M.J., et al.: Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet, 1983, 1, 1027.
76. Spatling L., Spatling G.: Magnesium supplementation in pregnancy: a double blind study. Br. J. Obstet. Gynecol., 1988, 95, 120-5.
77. Stasiak A., Słomko Z.: Suplementacja odżywiania kobiet ciężarnych. Klin. Perinatol. Gin., Supi VII: Niedobór jodu i jego skutki. Poznań, 1994.
78. Steegers-Theunissen R.P: Folate metabolism and neural tube defects: a review. Eur. J. Obstet. Gynecol., 1995, 61, 39.
79. Stene L.C., Ulriksen J., Magnus P, et al.: Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia, 2000, 43, 1093-8.
80. Szamotulska K, Szostak-Węgierek D.: Mala masa urodzeniowa a zespół X w wieku dorosłym („hipoteza Barkera"). Diabetologia Polska, 1999, 6, 56-61.
81. Transcript of the Folic Acid Subcommittee, Department of Health and Human Services; Arlington V.A., November 23 and 24, 1992.
82. Uauy R., Birch D.G., Birch E.E., et al.: Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates. Pediatr. Res., 1990, 28, 285.
83. Ubbink J.B.: Is an elevated circulating maternal homocysteine concentration a risk factor for neural tube defects? Nutr. Rev., 1995, 53, 173.
84. Vergel R.G., Sanchez L.R., Heredero B.L., et al.: Primary prevention of neural tube defects with folic acid supplementation. Cuban Experience Prenat Diagn., 1990, 10, 149.
85. Villar J., Repke J.T.: Calcium supplementation during pregnancy may reduce preterm delivery in high risk populations. Am. J. Obstet. Gynecol., 1990, 163, 1124.
86. Villar J., Repke J.T., Belizan J.M., et al.: Calcium supplementation reduces blood pressure during pregnancy: Results of a randomized controlled clinical trial. Obstet. Gynecol., 1987, 70, 317.
87. Viteri F.E.: The consequences of iron deficiency and anemia in pregnancy. W: Allen L., King J., Lönnerdal B., eds. Nutrient Regulation during Pregnancy, Lactation and Infant Growth. New York: Plenum Press, 1994, 127-39.
88. Wellinghausen N.: Immunobiology of gestational zinc deficiency. Br. J. Nutr., 2001, 85 (Suppl2), S81-6.
89. Westney O.E., Westney L.S., Johnson A.A., et al.: Nutrition, genital tract infection, hematologic values, and premature rupture of membranes among African American women. J. Nutr., 1994, 124, 987S-93S.
90. WHO Safe vitamin A dosage during pregnancy and lactation. Recommendations and report from a consultation. Micronutrient series. Geneva: World Health Organization, 1998, (WHO.NUT/98.4.).
92. Woods J.R. Jr, Plessinger M.A., Miller R.K.: Vitamins C and E: missing links in preventing preterm premature rupture of membranes? Am. J. Obstet. Gynecol., 2001, 185, 5-10.
93. Ziari S.A., Mireles VL., Cantu C.G., et al.: Serum vitamin A, vitamin E, and beta-carotene levels in preeclamptic women in northern Nigeria. Am. J. Perinatol., 1996, 13, 287-91.
94. Ziemlański S. (red): Normy żywienia człowieka. Fizjologiczne podstawy. PZWL, 2001, Warszawa.